rs397508229
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_000492.4(CFTR):c.1585-9412A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000492.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.1585-9412A>G | intron_variant | Intron 11 of 26 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152080Hom.: 0 Cov.: 32
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74290
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:4Uncertain:1Other:1
- -
This sequence change falls in intron 11 of the CFTR gene. It does not directly change the encoded amino acid sequence of the CFTR protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with cystic fibrosis (PMID: 20875776, 23349053). ClinVar contains an entry for this variant (Variation ID: 53284). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. -
This intronic CFTR variant has been identified in multiple individuals with features of cystic fibrosis who carry a second CF-causing variant. This variant (rs397508229) is rare (<0.1%) in a large population dataset (gnomAD: 1/152080 total alleles; 0.0006575%; no homozygotes) and has been reported in ClinVar (Variation ID: 53284). Functional studies demonstrate that this deep intronic variant creates a cryptic splice donor site that leads to aberrant splicing. We consider CFTR c.1585-9412A>G to be likely pathogenic. -
- -
The c.1585-9412A>G intronic pathogenic mutation results from an A to G substitution 9412 nucleotides upstream from coding exon 12 in the CFTR gene. This mutation (reported as c.1584+18672A>G) has been detected in multiple individuals affected with cystic fibrosis who have a pathogenic mutation on the other chromosome (Costantino L et al. Am. J. Respir. Cell Mol. Biol., 2013 May;48:619-25). In addition, this mutation has been shown to activate two out-of-frame pseudoexons (104 and 65 base pairs) by creating a splice donor site (Costantino L et al. J. Cyst. Fibros., 2010 Dec;9:411-8; Costantino L et al. Am. J. Respir. Cell Mol. Biol., 2013 May;48:619-25; Felício V et al. Clin. Genet., 2017 03;91:476-481). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at